Growth Metrics

Lineage Cell Therapeutics (LCTX) Free Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (3y) (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 24.91%
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 20.11%
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 14.71%
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn -10.65%
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 31.42%
10 Lineage Cell Therapeutics 325.89 Mn 261.99 Mn 1.73 Mn 10.67%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.67%
Dec 31, 2025 12.05%
Sep 30, 2025 15.09%
Jun 30, 2025 8.12%
Mar 31, 2025 -30.61%
Dec 31, 2024 -3.69%
Sep 30, 2024 -6.55%
Jun 30, 2024 2.14%
Mar 31, 2024 7.83%
Dec 31, 2023 -5.18%
Sep 30, 2023 1.34%
Jun 30, 2023 -15.40%
Mar 31, 2023 -31.42%
Dec 31, 2022 -12.63%
Sep 30, 2022 8.44%
Jun 30, 2022 10.13%
Mar 31, 2022 62.68%
Dec 31, 2021 -0.28%
Sep 30, 2021 13.19%
Jun 30, 2021 9.33%
Mar 31, 2021 10.97%
Dec 31, 2020 1.82%
Sep 30, 2020 16.19%
Jun 30, 2020 23.07%
Mar 31, 2020 15.39%
Dec 31, 2019 15.73%
Sep 30, 2019 7.17%
Jun 30, 2019 3.71%
Mar 31, 2019 13.97%
Dec 31, 2018 30.17%
Sep 30, 2018 13.97%
Jun 30, 2018 9.32%
Mar 31, 2018 -4.01%
Dec 31, 2017 12.61%
Sep 30, 2017 3.68%
Jun 30, 2017 4.72%
Mar 31, 2017 7.07%
Dec 31, 2016 -11.58%
Sep 30, 2016 -7.04%
Jun 30, 2016 -12.87%
Mar 31, 2016 -25.60%
Dec 31, 2015 -50.01%
Sep 30, 2015 -32.49%
Jun 30, 2015 -35.67%
Mar 31, 2015 -17.09%
Dec 31, 2014 -31.22%
Sep 30, 2014 -33.38%
Jun 30, 2014 -52.52%
Mar 31, 2014 -41.53%
Dec 31, 2013 -32.93%
Sep 30, 2013 -56.06%